Tobias Herold

9.3k total citations · 1 hit paper
121 papers, 2.9k citations indexed

About

Tobias Herold is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Tobias Herold has authored 121 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 38 papers in Molecular Biology and 24 papers in Surgery. Recurrent topics in Tobias Herold's work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cancer Genomics and Diagnostics (11 papers). Tobias Herold is often cited by papers focused on Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cancer Genomics and Diagnostics (11 papers). Tobias Herold collaborates with scholars based in Germany, United States and New Zealand. Tobias Herold's co-authors include Vindi Jurinović, Michael von Bergwelt‐Baildon, Johannes C. Hellmuth, Brian J. Lipworth, Matthias Klein, Tobias Weinberger, Karsten Spiekermann, Klaus H. Metzeler, Stefan K. Bohlander and Wolfgang Hiddemann and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Tobias Herold

114 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19

2020 687 citations Tobias Herold, Vindi Jurinović et al. profile →

Peers

Countries citing papers authored by Tobias Herold

Since Specialization

Citations

This map shows the geographic impact of Tobias Herold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Herold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Herold more than expected).

Fields of papers citing papers by Tobias Herold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Herold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Herold. The network helps show where Tobias Herold may publish in the future.

Co-authorship network of co-authors of Tobias Herold

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Herold. A scholar is included among the top collaborators of Tobias Herold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Herold. Tobias Herold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer 2023 ·ESMO Open ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marcel Wiesweg, Stefan Kasper, (unknown), Tobias Herold, (unknown), Brigitte Schumacher, (unknown), P. M. Markus, Jürgen Treckmann, Martin Schüler, Hans‐Ulrich Schildhaus, Jens T. Siveke	6
2	109P DNA damage repair pathways in biliary tract cancer: A new target for precision medicine? 2023 ·Annals of Oncology ·(unknown), (unknown), (unknown), (unknown), Tobias Herold, Stefan Kasper‐Virchow, Hans‐Ulrich Schildhaus, (unknown), Jens T. Siveke	1
3	Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia 2023 ·Leukemia ·Christian Rausch, Maja Rothenberg‐Thurley, Annika Dufour, Stephanie Schneider, (unknown), Cristina Sauerland, Dennis Görlich, Utz Krug, Wolfgang E. Berdel, Bernhard J. Woermann, Wolfgang Hiddemann, Jan Braess, Michael von Bergwelt‐Baildon, Karsten Spiekermann, Tobias Herold, Klaus H. Metzeler	45
4	HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy 2022 ·American Journal of Hematology ·Vincent Alcazer, Paola Bonaventura, Laurie Tonon, (unknown), (unknown), (unknown), Nicolas Chuvin, (unknown), Yann Estornes, Véronique Maguer‐Satta, (unknown), Alain Viari, Klaus H. Metzeler, Wolfgang Hiddemann, (unknown), Tobias Herold, Christophe Caux, Stéphane Depil	15
5	MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF 2021 ·Cell Death and Differentiation ·Xin Wang, Uris Ros, (unknown), (unknown), Julia Slotta‐Huspenina, Veronika Dill, Bo Shen, Run Shi, Tobias Herold, Claus Belka, Ritu Mishra, Florian Bassermann, Ana J. García‐Sáez, Philipp J. Jost	12
6	Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring <i>NRIP1-MIR99AHG</i> rearrangements 2021 ·Haematologica ·Paul Kerbs, Sebastian Vosberg, Stefan Krebs, Alexander Graf, Helmut Blum, (unknown), Aarif M.N. Batcha, Ulrich Mansmann, Dirk Metzler, Caroline A. Heckman, Tobias Herold, Philipp A. Greif	20
7	Extracorporeal Membrane Oxygenation in Predominantly Leuco- and Thrombocytopenic Haematologic/Oncologic Patients with Acute Respiratory Distress Syndrome - a Single-Centre Experience 2018 ·Oncology Research and Treatment ·Stephanie-Susanne Stecher, Georg Beyer, Elisabetta Goni, Johanna Tischer, Tobias Herold, Christoph Schulz, Mark op den Winkel, Hans‐Joachim Stemmler, (unknown)	13
8	Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data 2018 ·BMC Bioinformatics ·(unknown), Vindi Jurinović, Roman Hornung, Tobias Herold, Anne‐Laure Boulesteix	45
9	GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo 2016 ·Blood ·Caroline Pabst, Anne Bergeron, Vincent‐Philippe Lavallée, Jonathan R. Yeh, Patrick Gendron, Gudmundur L. Norddahl, Jana Krošl, Isabel Boivin, Éric Deneault, (unknown), Suzan Imren, Geneviève Boucher, Kolja Eppert, Tobias Herold, Stefan K. Bohlander, R. Keith Humphries, Sébastien Lemieux, Josée Hébert, Guy Sauvageau, Frédéric Barabé	115
10	Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL 2016 ·Journal of Hematology & Oncology ·Lars Fransecky, Martín Neumann, Sandra Heesch, Cornelia Schlee, Jutta Ortiz-Tánchez, Sandra Heller, Maximilian Mossner, Stefan Schwartz, Liliana H. Mochmann, Konstandina Isaakidis, Lorenz Bastian, Ursula R. Kees, Tobias Herold, Karsten Spiekermann, Nicola Gökbuget, Claudia D. Baldus	16
11	Detektion intrinsischer Band- und TFCC-Läsionen des Handgelenks: Indirekte vs. direkte MR-Arthrographie 2015 ·Der Unfallchirurg ·(unknown), Patrick Hoffstetter, Claudia Fellner, Tobias Herold, Michael Nerlich, Michaela Huber	1
12	Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia 2014 ·Leukemia ·(unknown), Klaus H. Metzeler, (unknown), Tobias Herold, (unknown), (unknown), Michela Carlet, Gina Walter, Tanja Hinrichsen, (unknown), M Grunert, Simon Schneider, Marion Subklewe, A Dufour, Stefan Fröhling, Klein Hg, Wolfgang Hiddemann, Irmela Jeremias, Karsten Spiekermann	58
13	High expression ofMZB1predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature 2012 ·Leukemia & lymphoma ·Tobias Herold, Medhanie Mulaw, Vindi Jurinović, Till Seiler, Klaus H. Metzeler, Annika Dufour, Stephanie Schneider, Purvi M. Kakadia, Karsten Spiekermann, Ulrich Mansmann, Wolfgang Hiddemann, Christian Buske, Martin Dreyling, Stefan K. Bohlander	23
14	Trends of Radiopharmaceutical Use at Mayo Clinic Rochester 2007 ·Journal of Nuclear Medicine Technology ·(unknown), (unknown), (unknown), J. C. Hung, Tobias Herold, Brian P. Mullan	1
15	Intra-arterial MR angiography in the iliac system: initial clinical experience with 25 patients 2006 ·British Journal of Radiology ·(unknown), N Zorger, Okka W. Hamer, Johannes Seitz, (unknown), Stefan Feuerbach, Wolfgang R. Nitz, M. Lenhart, Tobias Herold	5
16	Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension 2006 ·Peptides ·Roland Wiest, Lars Jurzik, Tobias Herold, Rainer H. Straub, J Schölmerich	19
17	Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency 2005 ·The Journal of Gene Medicine ·Ulrich Hacker, (unknown), David M. Kofler, (unknown), (unknown), Tobias Herold, Susan King, (unknown), Luca Perabò, Joseph E. Rabinowitz, Douglas M. McCarty, R. Jude Samulski, Michael Hallek, Hildegard Büning	51
18	Genauigkeit eines bildfreien Navigationssystemes für die Hüftpfannenimplantation – eine anatomische Studie / Accuracy of an Image-free Cup Navigation System – an Anatomical Study 2004 ·Biomedizinische Technik/Biomedical Engineering ·T. Kalteis, Johannes Beckmann, Tobias Herold, S. Zysk, H. Bäthis, L. Perlick, Joachim Grifka	19
19	Feasibility of MR-guided Angioplasty of Femoral Artery Stenoses Using Real-time Imaging and Intraarterial Contrast-enhanced MR Angiography 2004 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·(unknown), N Zorger, (unknown), Markus Völk, Johannes Seitz, Tobias Herold, Stefan Feuerbach, M. Lenhart, Wolfgang R. Nitz	15
20	Evaluation experimentell erzeugter Verletzungen der oberen Hals- wirbelsäule mit digitaler Röntgentechnik, Computertomographie und Magnetresonanztomographie 1999 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·(unknown), Tobias Herold, Uta Fischer, (unknown), J. Koebke, E. Grabbe, K.‐S. Saternus	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact